Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEE C-84 Booster Study
NCT00582088Phase 2Unknown
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Mar 2008
- Primary completion
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Venezuelan equine encephalitis vaccine C-84 in Venezuelan equine encephalomyelitis (VEE), sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Frequency of Adverse Events, Immunogenicity: TC-83 with PRNT80 >= 1:20 and 1 more. Status: unknown.
02
Drugs
Venezuelan equine encephalitis vaccine C-84
03
Conditions
Venezuelan equine encephalomyelitis (VEE)
Beyond the preview
Go deeper on NCT00582088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00582088.